Summit Therapeutics
SMMT
SMMT
97 hedge funds and large institutions have $86.3M invested in Summit Therapeutics in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 36 increasing their positions, 21 reducing their positions, and 6 closing their positions.
Holders
97
Holders Change
+4
Holders Change %
+4.3%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
36
Reduced
21
Closed
6
Calls
$896K
Puts
$101K
Net Calls
+$795K
Net Calls Change
-$1.14M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$18.3M |
2 |
2
Morgan Stanley
New York
|
$3.68M |
3 |
3
BlackRock
New York
|
$25.5M |
4 |
4
State Street
Boston,
Massachusetts
|
$6.41M |
5 |
5
Nuveen Asset Management
Chicago,
Illinois
|
$1.48M |